Garrett M. Brodeur, MD, is the Director of the Cancer Predisposition Program at CHOP and Associate Director of the Abramson Cancer Center at Penn. He has a special interest in the molecular biology, genetics and targeted therapy of neuroblastoma.
Partial Data by Infogroup (c) 2024. All rights reserved.